Cas 302839-17-4,4-[5-(2-cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidine-1-carboxylic acid <i>tert</i>-butyl ester

302839-17-4

Post Buying Request

Basic information

Product Name: 4-[5-(2-cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester
Synonyms: 4-[5-(2-cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester
CAS NO:302839-17-4
Molecular Formula:
Molecular Weight: 520.647
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[5-(2-cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-[5-(2-cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester(302839-17-4)
EPA Substance Registry System: 4-[5-(2-cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester(302839-17-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 302839-17-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

302839-17-4 Suppliers

Recommended suppliers

302839-17-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 302839-17-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,2,8,3 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 302839-17:
(8*3)+(7*0)+(6*2)+(5*8)+(4*3)+(3*9)+(2*1)+(1*7)=124
124 % 10 = 4
So 302839-17-4 is a valid CAS Registry Number.

302839-17-4Upstream product

302839-17-4Downstream Products

302839-17-4Relevant academic research and scientific papers

Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis

Revesz, Laszlo,Blum, Ernst,Di Padova, Franco E.,Buhl, Thomas,Feifel, Roland,Gram, Hermann,Hiestand, Peter,Manning, Ute,Rucklin, Gerard

, p. 3595 - 3599 (2007/10/03)

A library of trisubstituted oxazoles, thiazoles, imidazoles (1,2,4- and 2,4,5-substituted) and imidazo[1,2-b]pyridines was prepared and evaluated in vitro as p38α inhibitors and in vivo in several models of rheumatoid arthritis. Four structures - 32, 37,

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 302839-17-4